Neuronal SNARE proteins mediate neurotransmitter release at the synapse by facilitating the fusion of vesicles to the presynaptic plasma membrane. Cognate v-SNAREs and t-SNAREs from the vesicle and the plasma membrane, respectively, zip up and bring about the apposition of two membranes attached at the Cterminal ends. Here, we demonstrate that SNARE zippering can be modulated in the midways by wedging with small hydrophobic molecules. Myricetin, which intercalated into the hydrophobic inner core near the middle of the SNARE complex, stopped SNARE zippering in motion and accumulated the trans-complex, where the N-terminal region of v-SNARE VAMP2 is in the coiled coil with the frayed C-terminal region. Delphinidin and cyanidin inhibited N-terminal nucleation of SNARE zippering. Neuronal SNARE complex in PC12 cells showed the same pattern of vulnerability to small hydrophobic molecules. We propose that the half-zipped trans-SNARE complex is a crucial intermediate waiting for a calcium trigger that leads to fusion pore opening.
Neuronal SNARE proteins mediate neurotransmitter release at the synapse by facilitating the fusion of vesicles to the presynaptic plasma membrane. Cognate v-SNAREs and t-SNAREs from the vesicle and the plasma membrane, respectively, zip up and bring about the apposition of two membranes attached at the Cterminal ends. Here, we demonstrate that SNARE zippering can be modulated in the midways by wedging with small hydrophobic molecules. Myricetin, which intercalated into the hydrophobic inner core near the middle of the SNARE complex, stopped SNARE zippering in motion and accumulated the trans-complex, where the N-terminal region of v-SNARE VAMP2 is in the coiled coil with the frayed C-terminal region. Delphinidin and cyanidin inhibited N-terminal nucleation of SNARE zippering. Neuronal SNARE complex in PC12 cells showed the same pattern of vulnerability to small hydrophobic molecules. We propose that the half-zipped trans-SNARE complex is a crucial intermediate waiting for a calcium trigger that leads to fusion pore opening.
polyphenol | hemifusion | neurotransmission | neuron N eurotransmitter release at the synapse, which serves as the brain's major form of cell-cell communication, requires the fusion of synaptic vesicles with the presynaptic plasma membrane. Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate this synaptic fusion event (1) (2) (3) (4) (5) , and the formation of a four-helical bundle (6) (7) (8) is believed to generate the force required for fusion. A zipper model has been proposed for SNARE complex formation, initiating assembly at the N-terminal region and zipping toward the C-terminal membrane-proximal region (6) (7) (8) (9) . To account for fast neuroexocytosis, the SNAREs in primed readily releasable vesicles have been proposed as being partially zipped in the trans-configuration bridging the two membranes.
Although the structure of the fully assembled cis-SNARE complex, which is believed to represent the postfusion state, has been determined (10) , the structure of the trans-complex is poorly understood and is purely imaginary, most likely because of its inherently transient nature. Precisely linking the degrees of SNARE zippering to specific stages of membrane fusion seems to be prerequisite for determining the structure of the trans-complex and for providing answers to the questions of how fast fusion is controlled in neurons and how the trans-complexes set up the readily releasable vesicles with other regulatory proteins.
Here, we show that certain small hydrophobic molecules (SHM) enable layer-by-layer control of SNARE zippering by wedging into various points of the SNARE zipper. SNAREmediated membrane fusion is dissected via this wedge-like action of SHMs. Analysis of the captured replication fork-like structure allowed us to understand the basic architecture of the putative trans-complex.
Results

SNARE-Driven Membrane Fusion Can Be Controlled by SHMs with
Different Modes of Action. As an initial step to examine the feasibility of whether SHM works as a wedge for the SNARE zippering, 39 polyphenolic compounds representing 12 subgroups were screened for inhibitory activity against SNARE-driven proteoliposome fusion (11) . We used polyphenolic compounds as a source for SHM because they are abundant in nature and are known to be versatile in helical bundle binding (12) (13) (14) (15) . The SHMs displayed a wide range of inhibitory activity during the initial screen, which was conducted at a concentration of 20 μM, equivalent to the concentration of t-SNARE proteins used in the fusion assay (Table S1 ). The nine most effective compounds were selected for subsequent experiments, and the least effective compound, kaempferol, was used as a negative control. Next, the degree of inhibition of lipid mixing (Fig. 1A) and SNARE complex formation (Fig. 1B) were determined for each compound at a concentration of 10 μM. The extent of SNARE complex formation was assessed by exploiting the SDS-resistant property of the core complex (16) . For all 10 compounds tested, the degree of SNARE complex formation inhibition correlated well with that of lipidmixing inhibition (Fig. 1C) , suggesting that SHM-mediated inhibition of membrane fusion is likely a direct consequence of inhibition of SNARE zippering. The tested compounds did not cause liposome fusion without SNARE proteins and did not cause precipitation of proteoliposomes at the concentrations tested (Fig. S1A) . We exclude the possibility that SHMs inhibited anti-SNAP-25 antibody binding to SNARE complexes (Fig. S1B) . Thus, the results of the in vitro fusion assay indicate that certain SHMs are capable of down-regulating SNARE complex formation, thereby inhibiting membrane fusion in a concentrationdependent manner (Fig. S1C ).
We performed further experiments using the three most efficient compounds, delphinidin, cyanidin, and myricetin, as well as the least effective, kaempferol (insets in Fig. 1C) . First, by using soluble SNARE motifs, SHMs were shown to intercalate into the inner layer of the SNARE complex. SNARE complex-bound SHMs were detected by nitroblue tetrazolium staining, which allows colorimetric detection of protein-bound polyphenols, only when the SHMs were added before complex formation, indicating that the inhibitory SHMs intercalate into the inner layer of the core complex during helical bundle formation (Fig. 1D) . The SHMs did not bind to binary t-SNARE complex regardless of the presence or absence of the Habc domain and transmembrane domain of syntaxin 1 (Fig. S2) .
To gain further insight into the mechanism by which SHMs inhibit membrane fusion, the fusion step-specific effect on SNARE-dependent proteoliposome fusion was examined (17) . Preincubation of t-and v-SNARE vesicle mixtures at 4°C is known to enrich N-terminal, partially zipped complex and enhance membrane fusion when the temperature is subsequently elevated to 37°C. SHMs were added to the reaction either before or after this preincubation step (Fig. 1E) . SNARE-mediated fusion was dramatically reduced when myricetin, delphinidin, or cyanidin was added before the preincubation step, whereas kaempferol had only a slight effect (Fig. 1F) . In contrast, when the SHMs were introduced after the preincubation step, the effects became divergent. Myricetin largely retained its inhibitory activity, whereas delphinidin and cyanidin showed little inhibitory effect. The amount of SNARE complex formed correlated well with the results of the lipid-mixing assay (Fig. 1G ).
Binding Sites of SHMs in the SNARE Complex and the Effect of Differential Binding on Hemifusion. We performed Ala-scanning experiments to locate potential binding region of the three SHMs in the SNARE zipper. All amino acids located at internal a and d positions of the VAMP2 helix were mutated to alanine one at a time, with the exception of native alanine residues. P20A and P23A mutants were also prepared because the proline-rich region is known to have affinity to some polyphenols (18) , and VAMP2 contains the proline-rich region before the SNARE motif. The effect of each Ala mutation was assessed with the in vitro fusion assay ( Fig. 2A) . With only a few exceptions, most Ala mutations hampered SNARE-mediated fusion by ∼50%, emphasizing the importance of the conserved core residues for the fusion activity. The Ala mutants were then subjected to the lipid-mixing assay in the presence of an SHM. We reasoned that when a binding site for a particular SHM is mutated to Ala, the mutant would lose ability to bind the SHM, thereby relieving inhibition by that SHM (Fig. S3) . The relative fusion efficiency, defined as the ratio between the percentage maximum fluorescence intensity (PMF) measured in the presence of the drug to the PMF measured in the absence of the drug, was plotted along the VAMP2 helix sequence for each SHM. Myricetin appears to have two binding sites: a weak binding site coordinated by hydrophobic residues between residues 20 and 35 of VAMP2 and the corresponding t-SNARE hydrophobic layers and a strong binding site coordinated by the hydrophobic layers in the middle region (residues 49-63 of VAMP2 and the corresponding t-SNARE residues). In contrast, delphinidin and cyanidin both had only one strong binding site at the N-terminal region between residues 20 and 42. These results were consistent with the results from the preincubation experiments. It is noted that the proline-rich region also contributes to SHM binding to the N terminus of SNARE complex, perhaps through hydrophobic interaction (18) . Although high-resolution structures of SHM-containing SNARE complexes need to be determined for better understanding of binding mechanisms, we speculate that the proline-rich region caps the N-terminal SNARE bundle to enhance the SHM binding ( Fig. S6E and Fig. S7 ). We hypothesized that it would be possible to link the degree of SNARE zippering to specific stages of membrane fusion by harnessing the unique properties of each SHM. We measured hemifusion by using sodium dithionite that selectively kills fluorescent dyes in outer leaflets (19) . Myricetin inhibited inner-leaflet mixing efficiently but allowed outer-leaflet mixing, stalling as much as 80% of the fusion outcome at the hemifusion state (Fig. 2B) . In contrast, delphinidin and cyanidin had just a slight effect on the fraction of hemifusion (Fig. 2B and Fig. S4 ). Together, our results raise the possibility that myricetin arrests membrane fusion at the hemifusion state by wedging into the middle region of the SNARE zipper.
Overall Fold of the Half-Zipped SNARE Complex. To determine the rough structure of SNARE zipper wedged by myricetin, fluorescence-quenching assays were performed with Cy5-labeled VAMP2 mutants (Fig. 3) . Five Cy5-labeled VAMP2 mutants were prepared: Q33C and T35C to probe N-terminal zippering, L54C and R56C for middle region zippering, and D68C for C-terminal zippering. F O /F, where F O and F represent fluorescence intensity measured in the absence or presence of the fluorescence quencher acrylamide, respectively, increases if acrylamide is readily accessible to Cy5, indicating the labeled position is frayed. Conversely, the slope is less affected by the quencher when the Cy5-label is positioned in the coiled-coil region. In this regard, preincubation at 4°C (Fig. 3, scheme A) seems to result in the replication fork-like SNARE zipper, where the N-terminal region of VAMP2 is in the coiled-coil structure and the C-terminal region remains frayed. After membrane fusion at 37°C (Fig. 3, scheme B) , all labeled VAMP2 residues appeared to participate in SNARE complex formation. By contrast, in the presence of myricetin (Fig. 3, scheme D) , the fluorescence-quenching pattern was similar to those of scheme A, indicating that SNARE zipper wedged by myricetin has the frayed C terminus.
Dissection of SNARE-Dependent Membrane Fusion in PC12 Cells with
SHMs. The next natural question is whether these observations are also true in live cells. First, we tested whether the SHMs could regulate SNARE complex formation in live cells. We prepared NGF-treated PC12 cells loaded with [ 3 H]noradrenaline. Based on the in vitro results, we expected that the SHM binding sites in the SNARE complexes would only be exposed during recycling of SNARE proteins. To induce SNARE recycling, the cells were pretreated with a high concentration of KCl followed by immediate addition of SHMs. A high concentration of KCl is known to induce depolarization of PC12 cells leading to SNARE-mediated membrane fusion and release of neurotransmitters (20) .
After high-K + pretreatment (Fig. 4A, red box) , neurotransmitter release was strongly inhibited by SHM exposure (Fig. 4B,  red bars) . The three most competent compounds, delphinidin, cyanidin, and myricetin, showed 75-80% inhibition at 10 μM, comparable to the calcium channel blocker verapamil (21, 22) and only slightly lower than the Clostridium botulinum neurotoxin D T  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  T  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  T  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  W T  P2 (BoNT/D). This high-K + pretreatment experiment appeared to mirror the in vitro preincubation experiment in which SHMs were added before 4°C preincubation ( Fig. 1 E and F) . Alternatively, the in vitro results of adding SHMs after 4°C preincubation were expected to correspond to those from the neuronal cells without high-K + pretreatment (Fig. 4A, blue box) . Only myricetin showed a significant inhibitory effect on neuroexocytosis (Fig. 4B, blue bars) , which is consistent with our in vitro observations that myricetin hampered C-terminal zippering by wedging the half-zipped partial complex.
Membrane proteins were extracted from PC12 cells and analyzed by Western blotting using an antibody against SNAP-25 (Fig.  4C) . Depolarization by high K + indeed induced SDS-resistant SNARE complex formation (low K + vs. high K + ). In the presence of SHMs, depolarization-induced SNARE complex formation was reduced, which is in agreement with the neurotransmitter release results. Delphinidin and cyanidin effectively reduced SNARE complex formation only when the neuronal cells were pretreated with high-K + solution (Fig. 4C, red box) . In contrast, myricetin effectively reduced SDS-resistant complex formation even without high-K + pretreatment (Fig. 4C, blue box) . Thus, the conformation of the trans-SNARE complex in neuronal cells is likely to be similar to that observed in vitro, where the delphinidin-and cyanidinbinding sites are concealed inside the N-terminal bundle and the C-terminal stronger myricetin-binding site is not yet zipped.
Discussion
In the present study, it was shown that dynamic SNARE zippering process could be stopped at the point of interest by wedging an appropriate SHM into the zipper. Delphinidin and cyanidin wedge into the SNARE zipper at the far N terminus (∼P20-V42 of VAMP2), thereby preventing N-terminal nucleation of SNARE complex formation (Fig. S8F) . Myricetin stops subsequent C-terminal zippering by wedging into the middle region of the SNARE zipper after the N-terminal half is zipped (Fig. S8G) . By harnessing these unique characteristics of SHMs, we dissected SNARE-driven membrane fusion and tried to link the degree of SNARE zippering to the specific membranefusion intermediates.
Preincubation at 4°C is known to enhance membrane fusion at the subsequently elevated temperature. This preincubation step is thought to accumulate the N-terminal partial complexes (Fig. S8A) , which undergo complete zippering in a synchronized manner when the temperature is raised (11) . When t-vesicles were mixed with vesicles containing Cy5-labeled VAMP2 at 4°C, we could confirm the formation of the N-terminal partial complex with frayed C-terminal SNARE motifs (Fig. 3) . The partial complex, however, has never been captured at physiological temperatures. The arrested zippering at physiological temperature by myricetin provides information about the trans-complex. Because the myricetin binding site is predicted to be coordinated by the hydrophobic residues of VAMP2 ∼N49-L63 and corresponding t-SNARE residues ( Fig. 2A) , and the partial complex formed by 4°C preincubation is susceptible to myricetin (Fig. 1  E-G) , the results suggested that the region of VAMP2 after N49 remains unzipped in the partial complex. Because this partial complex is not susceptible to delphinidin or cyanidin, which bind before V42, the SHMs-assisted assays suggest the possibility that the N-terminal region up to M46 forms a coiled coil during 4°C preincubation. Static fluorescence-quenching experiments (Fig.  3 ) also support that this halfway N-terminal zippering up to M46 with the frayed C-terminal half of VAMP2 is likely to represent the trans-complex (Fig. S8D′) . It is believed that SNARE complex formation starts at the membrane-distal N-terminal region and zips toward the membrane-proximal C-terminal region (6-9), thereby effectively forcing the apposition of the two membranes. Also, it is widely accepted that N-terminal assembly of SNARE proteins underlies vesicle priming, whereas assembly of the C-terminal end drives fusion. In this model, an intermediate state of the SNARE complex is associated with the primed vesicle state, and subsequent C-terminal assembly, assisted by other proteins such as synaptotagmin and complexin, leads to membrane fusion and the relaxation of trans-SNAREpins into cis-SNARE complexes. Many of recent studies on complexin-and synaptotagmin-modulated fast neuroexocytosis presume this model to be true to account for their findings (3, 10, (23) (24) (25) (26) (27) . However, our results raise another possibility, where N-terminal half zippering, which had been merely considered responsible for vesicle docking, might be sufficient to induce hemifusion and is the minimal zippering degree for membrane hemifusion. Our results suggest that the zippering degree responsible for hemifusion could be only up to residue 46 of VAMP2 (Fig. S8D) .
Evidence indicates that the hemifusion state is a stable intermediate of exocytosis in neuronal cells in vivo (28) , and two membranes may be hemifused before Ca 2+ influx (29, 30) . The similar responses to SHM treatments observed in both reconstituted proteoliposomes and neuronal PC12 cells suggest that the halfway zippering-mediated hemifusion state (Fig. S8G ) may be also true in the neuron. The hemifusion state likely progresses toward the fusion pore when calcium triggers full SNARE zippering (Fig. S8E) , with the help of other regulatory proteins such as synaptotagmin and complexin (31) . We note, however, that there are contradictory results against the hemifusion state (32), and there is the possibility, although unlikely, that myricetin's interaction with the membrane is in part responsible for hemifusion arrest (Fig. S7) .
BoNTs elicit neuron-specific flaccid paralysis by specifically cleaving neuronal SNARE proteins. After the realization of the therapeutic potentials of these otherwise fatal toxins, the Food and Drug Administration approved the controlled use of BoNT/ A for the treatment of several hypersecretion-related neurological diseases, such as strabismus, blepharospam, hemifacial spasm, and cervical dystonia (33) . Recently, the cosmetic use of these toxins for treating glabellar facial lines and axillary hyperhidrosis has gained immense popularity. Can small molecules, with more conventional drug-like properties, also regulate SNARE complex formation and consequent neuroexocytosis? Promisingly, our results imply that SNARE-wedging small molecules might serve as SNARE-specific drugs, which will definitely provide a tractable avenue in treating a variety of human hypersecretion diseases. These small molecules can serve as general chemical platforms from which unique and potent SNAREspecific drugs can be derived.
Materials and Methods
Materials. 1-Palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphatidylserine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoserine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PS), and 1,2-dioleoylsn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (rhodamine-PE) were obtained from Avanti Polar Lipids. RPMI medium 1640, penicillin-streptomycin, horse serum, and FBS were purchased from GIBCO/ BRL. Recombinant BoNT/D light chain was purchased from List Biological Laboratories. All other chemicals, including polyphenolic compounds, were purchased from Sigma-Aldrich.
PC12 Cell Culture and Determination of [
3 H]Noradrenaline Release. PC12 cells were purchased from the Korean Cell Line Bank (Seoul, Korea). The PC12 cells were plated onto poly-D-lysine-coated culture dishes and were maintained in RPMI medium 1640 containing 100 μg/mL streptomycin, 100 U/mL penicillin, 2 mM L-glutamine, and 10% heat-inactivated FBS at 37°C in a 5% CO 2 incubator. The cell cultures were split once a week, and the medium was refreshed three times a week. PC12 cells were treated with NGF (7S, 50 ng/mL, Invitrogen) for 5 Statistical Analysis. All experimental data were examined by ANOVA procedures, and significant differences among the means from three to five repeats were assessed with Duncan's multiple range tests and the Statistical Analysis System, version 8.2 (SAS Institute).
